Nbryo has released a new embryo multiplication technology, saying that genetic gain via assisted bovine reproduction is now easier and more cost effective than ever before.
The world-first breakthrough in cattle IVF comes after more than 16 years of research and development.
Stage one has already lowered the cost of Nbryo’s Grade 1 embryo production, with further reductions expected as the level of multiplication achieved increases.
“With this breakthrough, producers can expect to achieve the same embryo numbers from half the number of donors and using half the amount of semen than a conventional IVF program,” Nbryo Chief Executive Officer Paul Niven said.
“This means more calves can now be produced from females of the highest genetic merit - accelerating genetic gain for less cost.”
Rob Costello of Nairn Park Angus, Walcha, acknowledged that while there are risks with being an early adopter of technology, including a small reduction in pregnancy rates, he believes the trade-off is well worth it.
“If we can multiply our leading genetics at a faster rate and at comparable costs, it should allow our commercial clients greater access to these top genetics at reduced prices. The flow on effect along the chain is a win win for everyone.”
Unlike conventional “twinning”, where a single early-stage embryo is manually split into two or more embryos, Nbryo has revealed its process does not involve embryo splitting or cloning. Instead, it uses a patented biological process that both increases embryo yield and improves embryo development rates (EDR) - producing more Grade 1 embryos at lower cost.
According to Nbryo, field trials indicate that the first stage of this technology can double embryo production compared to conventional IVF, reducing costs and transforming the economics of embryo transfer.
Nybryo reports that the technology will be particularly good for low embryo producing breeds, such as wagyu.
Associate Professor Margot Day, Nbryo’s Lead Scientist from the University of Sydney, said the team’s innovation represents a fundamental leap in reproductive biotechnology.
“By multiplying embryos through the proprietary process and simultaneously improving embryo development rates, we’re able to make elite genetics more accessible for commercial producers. Embryo quality and viability remain consistently high marking a new era in reproductive biotechnology, with further multiples in development.”
This breakthrough is one of a number of assisted breeding technologies currently under development at Nbryo. Also nearing completion is an embryo transfer (ET) device which will allow an artificial insemination (AI) technician to perform transfers without the need for a specialist embryo transfer veterinarian or an epidural.
Nbryo started commercial production of multiplied embryos this month and is now taking bookings for 2026 ovum pick-ups, conventional and multiplied embryo production, and embryo transfers.
Contact Nbryo for bookings and enquiries.